Efficacy and Safety of SHR0302, a Highly Selective Janus Kinase 1 Inhibitor, in Patients with Moderate to Severe Atopic Dermatitis: A Phase II Randomized Clinical Trial

Phase Ii ◽

Janus Kinase ◽

Efficacy And Safety ◽

Janus Kinase 1

Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: a phase II, multicentre, randomized, vehicle-controlled clinical study

British Journal of Dermatology ◽

10.1111/bjd.16014 ◽

2018 ◽

Vol 178 (2) ◽

pp. 424-432 ◽

Cited By ~ 59

Author(s):

H. Nakagawa ◽

O. Nemoto ◽

A. Igarashi ◽

T. Nagata

Keyword(s):

Atopic Dermatitis ◽

Clinical Study ◽

Phase Ii ◽

Kinase Inhibitor ◽

Janus Kinase ◽

Efficacy And Safety ◽

Japanese Adult ◽

Janus Kinase Inhibitor ◽

Controlled Clinical Study

Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: a phase II, multicentre randomized, vehicle-controlled clinical study

British Journal of Dermatology ◽

10.1111/bjd.16295 ◽

2018 ◽

Vol 178 (2) ◽

pp. e169-e169

Author(s):

H. Nakagawa ◽

O. Nemoto ◽

A. Igarashi ◽

T. Nagata

Keyword(s):

Atopic Dermatitis ◽

Clinical Study ◽

Phase Ii ◽

Kinase Inhibitor ◽

Janus Kinase ◽

Efficacy And Safety ◽

Japanese Adult ◽

Janus Kinase Inhibitor ◽

Controlled Clinical Study

Lactobacillus salivarius plus fructo-oligosaccharide is superior to fructo-oligosaccharide alone for treating children with moderate to severe atopic dermatitis: a double-blind, randomized, clinical trial of efficacy and safety

British Journal of Dermatology ◽

10.1111/j.1365-2133.2011.10596.x ◽

2011 ◽

Vol 166 (1) ◽

pp. 129-136 ◽

Cited By ~ 51

Author(s):

K.-G. Wu ◽

T.-H. Li ◽

H.-J. Peng

Keyword(s):

Clinical Trial ◽

Atopic Dermatitis ◽

Efficacy And Safety ◽

Lactobacillus Salivarius ◽

Double Blind

Kinetic‐Pharmacodynamic Model of Platelet Time Course in Patients With Moderate‐to‐Severe Atopic Dermatitis Treated With Oral Janus Kinase 1 Inhibitor Abrocitinib

CPT Pharmacometrics & Systems Pharmacology ◽

10.1002/psp4.12548 ◽

2020 ◽

Vol 9 (10) ◽

pp. 553-560

Author(s):

Elena Soto ◽

Christopher Banfield ◽

Pankaj Gupta ◽

Mark C. Peterson

Keyword(s):

Atopic Dermatitis ◽

Time Course ◽

Pharmacodynamic Model ◽

Janus Kinase ◽

Janus Kinase 1

A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis

Veterinary Dermatology ◽

10.1111/vde.12478 ◽

2017 ◽

Vol 28 (6) ◽

pp. 593-e145 ◽

Cited By ~ 21

Author(s):

Hilde Moyaert ◽

Leen Van Brussel ◽

Stasia Borowski ◽

Monica Escalada ◽

Sean P. Mahabir ◽

...

Keyword(s):

Clinical Trial ◽

Atopic Dermatitis ◽

Efficacy And Safety

Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial

American Journal of Clinical Dermatology ◽

10.1007/s40257-019-00478-y ◽

2019 ◽

Vol 21 (1) ◽

pp. 119-131 ◽

Cited By ~ 8

Author(s):

Amy S. Paller ◽

Ashish Bansal ◽

Eric L. Simpson ◽

Mark Boguniewicz ◽

Andrew Blauvelt ◽

...

Keyword(s):

Clinical Trial ◽

Atopic Dermatitis ◽

Post Hoc

Pilot study of a customized nanotextile wet garment treatment on moderate and severe atopic dermatitis: A randomized clinical trial

Pediatric Dermatology ◽

10.1111/pde.13981 ◽

2019 ◽

Vol 37 (1) ◽

pp. 52-57

Author(s):

Huiling He ◽

Mark Jean‐Aan Koh ◽

Haur Yueh Lee ◽

Seng Bin Ang

Keyword(s):

Clinical Trial ◽

Atopic Dermatitis ◽

Pilot Study ◽

Severe Atopic Dermatitis

Efficacy and safety of indigo naturalis ointment in Treating Atopic Dermatitis: A randomized clinical trial

Journal of Ethnopharmacology ◽

10.1016/j.jep.2019.112477 ◽

2020 ◽

Vol 250 ◽

pp. 112477 ◽

Cited By ~ 1

Author(s):

Yin-Ku Lin ◽

Shu-Han Chang ◽

Chin-Yi Yang ◽

Lai-Chu See ◽

Be-Han Lee ◽

...

Keyword(s):

Clinical Trial ◽

Atopic Dermatitis ◽

Efficacy And Safety ◽

Indigo Naturalis

Efficacy and safety of topical delgocitinib (JTE-052), janus kinase inhibitor, in Japanese pediatric patients with atopic dermatitis: A phase II, randomized, double-blind, vehicle-controlled study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2019.06.224 ◽

2019 ◽

Vol 81 (4) ◽

pp. AB53

Keyword(s):

Atopic Dermatitis ◽

Phase Ii ◽

Pediatric Patients ◽

Kinase Inhibitor ◽

Janus Kinase ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Janus Kinase Inhibitor

517 Effects of the oral janus kinase 1 (JAK1) inhibitor PF-04965842 on patient-reported outcomes (PROs) in adults with moderate to severe atopic dermatitis (AD)

Journal of Investigative Dermatology ◽

10.1016/j.jid.2018.03.525 ◽

2018 ◽

Vol 138 (5) ◽

pp. S88 ◽

Cited By ~ 1

Author(s):

E. Simpson ◽

A. Wollenberg ◽

R. Bissonnette ◽

J. Silverberg ◽

J. Papacharalambous ◽

...

Keyword(s):

Atopic Dermatitis ◽

Patient Reported Outcomes ◽

Janus Kinase ◽

Janus Kinase 1 ◽

Patient Reported